SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is currently trending as shareholders react to the company's annual meeting proposals, which include authorization for a potential reverse stock split. While some in the community are optimistic about Tonmya prescription growth and recent insider buying, others remain deeply skeptical, citing a long history of dilution and the stock's significant decline since its product launch.

Daddy Darth Vader

The community is currently caught in a "daddy war" rivalry between various tokens, driving intense debate over leadership credibility, alleged market manipulation, and the potential for rapid gains. Discussions are split between investors advocating for loyal community building and skeptics warning of a high-risk environment characterized by potential rug pulls and pump-and-dump mechanics.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing heightened community debate as investors weigh strong dividend yields and favorable technical setups against ongoing concerns over pipeline growth and regulatory headwinds from potential pharmaceutical tariffs. While some traders are focused on short-term option signals and a possible breakout above key resistance, others remain skeptical, pointing to the company's historical performance and the competitive pressure in the obesity and oncology markets.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense investor debate as shareholders weigh the company's defensive cash-heavy strategy against its persistent underperformance compared to the broader market. While some investors view the stock as a stable, undervalued hedge during volatility, others are increasingly vocal about frustration with management's capital allocation and a lack of aggressive growth, particularly as leadership transitions to Greg Abel.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is garnering intense community focus as traders weigh long-term infrastructure potential against recent price volatility and concerns over institutional adoption. Conversations are currently polarized between believers in the project's foundational role in tokenized real-world assets and those frustrated by its recent underperformance compared to the broader market.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors weigh its unique 'phygital' business model against broader market volatility, with many users debating whether its retail footprint and upcoming product initiatives signal a long-term recovery. Community sentiment is deeply divided between long-term holders advocating for accumulation and skeptics wary of its recent price action and high concentration among top wallets.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is trending as investors weigh recent institutional moves and analyst coverage against short-term volatility following an abrupt board shakeup. The community remains focused on high short interest and anticipation for the upcoming quarterly earnings, with bulls emphasizing strong fundamental growth and potential for a short squeeze despite ongoing market fluctuations.

Cantor Equity Partners II, Inc. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Cantor Equity Partners II is gaining attention as it prepares to merge with Securitize, a leading infrastructure provider in the real-world asset tokenization space. The community is focused on the company's institutional backing from major financial firms and the potential for the upcoming ticker change to trigger significant growth as tokenization becomes a broader Wall Street theme.

iShares Trust - iShares China Large-Cap ETF

iShares China Large-Cap ETF

Investors are closely monitoring the iShares China Large-Cap ETF as the community debates whether the sector is approaching a tradeable market bottom amid shifting geopolitical tensions, U.S.-China trade negotiations, and internal Chinese economic policy updates. While some market participants are actively adding the symbol to watchlists and identifying potential bullish reversals, others remain cautious, pointing to persistent concerns over deflation, property market instability, and the impact of looming tariff threats on long-term growth prospects.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is capturing significant investor attention as it approaches critical clinical catalysts, specifically interim data for its Phase 2 study of KYV-101 in generalized myasthenia gravis and upcoming presentations on stiff-person syndrome. The community is actively discussing the company's strong institutional backing and the potential for a first-to-market advantage in CAR-T autoimmune therapies, with many traders viewing the current valuation as a notable entry point ahead of these milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KEYS $337.81 and we still have a month to run into earnings. Victory lap for @Kornie7

K. A.

Stubby Brown

StockTwits for iOS

Keysight Technologies Inc

 $337.81 and we still have a month to run into earnings. Victory lap for 